Trials / Sponsors / AlphaVax, Inc.
AlphaVax, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza Influenza | Phase 1 / Phase 2 | 2008-06-01 |
| Completed | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancie Colorectal Cancer, Breast Cancer, Lung Cancer | Phase 1 / Phase 2 | 2007-09-01 |
| Completed | A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza Influenza | Phase 1 / Phase 2 | 2007-04-01 |
| Completed | A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) Cytomegalovirus Infections | Phase 1 | 2007-04-01 |
| Completed | Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults HIV Infections | Phase 1 | 2004-10-01 |
| Completed | Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa HIV Infections | Phase 1 | 2003-07-01 |